Filing Flows › Xilio Therapeutics (XLO) › How it makes money
How Xilio Therapeutics (XLO) makes money
Xilio Therapeutics (XLO) made $18.7M of revenue in the second quarter 2026 (Q2 2026), +131% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $18.7M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $18.7M | +131% |
| Q1 2026 | $12.6M | +332% |
| Q4 2025 | $13.7M | +694% |
| Q3 2025 | $19.1M | +742% |
| Q2 2025 | $8.1M | +243% |
| Q1 2025 | $2.9M | — |
| Q4 2024 | $1.7M | — |
From Xilio Therapeutics' 10-Q filed Aug 12, 2026 (on EDGAR).
Questions
How does Xilio Therapeutics make money?
Xilio Therapeutics (XLO) made $18.7M of revenue in the second quarter 2026 (Q2 2026), +131% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.